Raz et al further compared the survival curves of two different lung-sparing resection techniques (lobectomy and sublobectomy) vs a defined no-treatment group that also included a sample (51 of 306) of patients who underwent endoscopic tumor destruction with laser, cautery/fulguration, or otherwise specified procedures. We believe this approach is incorrect. Indeed, endoscopic treatment seems reasonably safe and effective in typical, noninvasive, lymph node-negative carcinoids., Although carcinoid recurrence has been shown to occur more frequently in patients managed endoscopically than in surgically treated patients, morbidity and long-term mortality rates are extremely low. In a case series of 35 patients with endoscopically resected carcinoids, Cavaliere et al reported no recurrence after a follow-up period of up to 198 months. In another series of 28 patients undergoing endobronchial treatment, the median follow-up was 8.8 years, and the 1- and 10-year survival rates were 89% and 84%, respectively. Among survivors, 100% and 94% were disease free at 1 and 10 years.